The WACC of Shield Therapeutics PLC (STX.L) is 29.0%.
Range | Selected | |
Cost of equity | 8.30% - 11.20% | 9.75% |
Tax rate | 2.20% - 2.90% | 2.55% |
Cost of debt | 7.00% - 96.50% | 51.75% |
WACC | 7.6% - 50.5% | 29.0% |
Category | Low | High |
Long-term bond rate | 4.0% | 4.5% |
Equity market risk premium | 6.0% | 7.0% |
Adjusted beta | 0.72 | 0.88 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 8.30% | 11.20% |
Tax rate | 2.20% | 2.90% |
Debt/Equity ratio | 0.91 | 0.91 |
Cost of debt | 7.00% | 96.50% |
After-tax WACC | 7.6% | 50.5% |
Selected WACC | 29.0% | |